• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁过载诱导骨髓增生异常综合征中的氧化应激及其细胞后果。

Iron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae.

机构信息

Faculty of Science, Department of Chemistry, Princeton University, Princeton, NJ, USA.

St. Paul's Hospital and the University of British Columbia, Vancouver, BC, Canada.

出版信息

Crit Rev Oncol Hematol. 2021 Jul;163:103367. doi: 10.1016/j.critrevonc.2021.103367. Epub 2021 May 29.

DOI:10.1016/j.critrevonc.2021.103367
PMID:34058341
Abstract

The myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders. MDS patients often require red blood cell transfusions, resulting in iron overload (IOL). IOL increases production of reactive oxygen species (ROS), oxygen free radicals. We review and illustrate how IOL-induced ROS influence cellular activities relevant to MDS pathophysiology. ROS damage lipids, nucleic acids in mitochondrial and nuclear DNA, structural proteins, transcription factors and enzymes. Cellular consequences include decreased metabolism and tissue and organ dysfunction. In hematopoietic stem cells (HSC), consequences of ROS include decreased glycolysis, shifting the cell from anaerobic to aerobic metabolism and causing HSC to exit the quiescent state, leading to HSC exhaustion or senescence. ROS oxidizes DNA bases, resulting in accumulation of mutations. Membrane oxidation alters fluidity and permeability. In summary, evidence indicates that IOL-induced ROS alters cellular signaling pathways resulting in toxicity to organs and hematopoietic cells, in keeping with adverse clinical outcomes in MDS.

摘要

骨髓增生异常综合征(MDS)是一种克隆性造血干细胞疾病。MDS 患者常需要输血,导致铁过载(IOL)。IOL 增加活性氧(ROS)的产生,即氧自由基。我们回顾并说明了 IOL 诱导的 ROS 如何影响与 MDS 病理生理学相关的细胞活动。ROS 会破坏线粒体和核 DNA 中的脂质、核酸、结构蛋白、转录因子和酶。细胞后果包括代谢减少和组织及器官功能障碍。在造血干细胞(HSC)中,ROS 的后果包括糖酵解减少,使细胞从无氧代谢转变为有氧代谢,并导致 HSC 退出静止状态,从而导致 HSC 衰竭或衰老。ROS 会氧化 DNA 碱基,导致突变积累。膜氧化会改变流动性和通透性。总之,有证据表明,IOL 诱导的 ROS 改变了细胞信号通路,导致器官和造血细胞毒性,与 MDS 的不良临床结果一致。

相似文献

1
Iron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae.铁过载诱导骨髓增生异常综合征中的氧化应激及其细胞后果。
Crit Rev Oncol Hematol. 2021 Jul;163:103367. doi: 10.1016/j.critrevonc.2021.103367. Epub 2021 May 29.
2
The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working Group.口服铁螯合剂地拉罗司对骨髓增生异常综合征患者铁过载和氧化应激的影响:以色列 MDS 工作组的一项研究。
Acta Haematol. 2024;147(4):427-434. doi: 10.1159/000535749. Epub 2023 Dec 16.
3
Unraveling the mechanisms behind iron overload and ineffective hematopoiesis in myelodysplastic syndromes.解析骨髓增生异常综合征中铁过载及无效造血背后的机制。
Leuk Res. 2017 Nov;62:108-115. doi: 10.1016/j.leukres.2017.10.001. Epub 2017 Oct 5.
4
Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox.地拉罗司治疗输血依赖型骨髓增生异常综合征患者铁介导的氧化 DNA 损伤的改善作用。
Free Radic Biol Med. 2012 Aug 15;53(4):643-8. doi: 10.1016/j.freeradbiomed.2012.06.006. Epub 2012 Jun 15.
5
New insights into transfusion-related iron toxicity: Implications for the oncologist.输血相关铁毒性的新见解:对肿瘤学家的启示。
Crit Rev Oncol Hematol. 2016 Mar;99:261-71. doi: 10.1016/j.critrevonc.2015.11.017. Epub 2015 Nov 27.
6
Myelodysplastic syndromes and the role of iron overload.骨髓增生异常综合征及铁过载的作用。
Am J Health Syst Pharm. 2010 Apr;67(7 Suppl 2):S3-9. doi: 10.2146/ajhp090645.
7
Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes.红细胞输注与铁过载在骨髓增生异常综合征患者治疗中的应用
Cancer. 2008 Mar 1;112(5):1089-95. doi: 10.1002/cncr.23280.
8
Hematologic improvement with iron chelation therapy in myelodysplastic syndromes: Clinical data, potential mechanisms, and outstanding questions.铁螯合疗法在骨髓增生异常综合征中的血液学改善:临床数据、潜在机制和悬而未决的问题。
Crit Rev Oncol Hematol. 2019 Sep;141:54-72. doi: 10.1016/j.critrevonc.2019.06.002. Epub 2019 Jun 10.
9
Impact of iron overload by transfusion on survival and leukemia transformation of myelodysplastic syndromes in a single center of China.中国单中心研究输血导致铁过载对骨髓增生异常综合征患者生存和白血病转化的影响。
Hematology. 2021 Dec;26(1):874-880. doi: 10.1080/16078454.2021.1989806.
10
HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross-sectional study.骨髓增生异常综合征患者的HFE基因突变与氧化损伤生物标志物及其与输血性铁过载的关系:一项观察性横断面研究
BMJ Open. 2015 Apr 3;5(4):e006048. doi: 10.1136/bmjopen-2014-006048.

引用本文的文献

1
Oxidative Stress and Mitochondrial Dysfunction in Myelodysplastic Syndrome: Roles in Development, Diagnosis, Prognosis, and Treatment.骨髓增生异常综合征中的氧化应激与线粒体功能障碍:在发生、诊断、预后及治疗中的作用
Int J Mol Sci. 2025 Jul 3;26(13):6415. doi: 10.3390/ijms26136415.
2
Iron chelation therapy in myelodysplastic syndromes and allogeneic hematopoietic cell transplantation, a delicate balance.骨髓增生异常综合征中的铁螯合疗法与异基因造血细胞移植:一种微妙的平衡
Blood Rev. 2025 Jun 23:101319. doi: 10.1016/j.blre.2025.101319.
3
Advances and challenges in the treatment of myelodysplastic syndromes.
骨髓增生异常综合征治疗的进展与挑战
Exp Hematol Oncol. 2025 Jun 18;14(1):87. doi: 10.1186/s40164-025-00678-9.
4
Curcumin attenuates myocardial ischemia‑reperfusion‑induced autophagy‑dependent ferroptosis via Sirt1/AKT/FoxO3a signaling.姜黄素通过Sirt1/AKT/FoxO3a信号通路减轻心肌缺血-再灌注诱导的自噬依赖性铁死亡。
Int J Mol Med. 2025 Mar;55(3). doi: 10.3892/ijmm.2025.5492. Epub 2025 Jan 24.
5
Redox biomarker levels in patients with myelodysplastic syndrome.骨髓增生异常综合征患者的氧化还原生物标志物水平。
Biomed Rep. 2025 Jan 14;22(3):45. doi: 10.3892/br.2025.1923. eCollection 2025 Mar.
6
Hepatocyte-specific NR5A2 deficiency induces pyroptosis and exacerbates non-alcoholic steatohepatitis by downregulating ALDH1B1 expression.肝实质细胞特异性 Nr5a2 基因缺失通过下调 Aldh1b1 表达诱导细胞焦亡加剧非酒精性脂肪性肝炎。
Cell Death Dis. 2024 Oct 23;15(10):770. doi: 10.1038/s41419-024-07151-1.
7
Early Post-Transplant Serum Ferritin Levels as Predictive Biomarkers for Severe Acute Graft-Versus-Host Disease in Pediatric Umbilical Cord Blood Transplantation for Acute Leukemia.早期移植后血清铁蛋白水平可作为急性白血病儿童脐血移植后严重急性移植物抗宿主病的预测生物标志物。
Ann Transplant. 2024 Aug 27;29:e944156. doi: 10.12659/AOT.944156.
8
Assessment of Total Antioxidant Capacity, 8-Hydroxy-2'-deoxy-guanosine, the Genetic Landscape, and Their Associations in -Negative Chronic and Blast Phase Myeloproliferative Neoplasms.评估总抗氧化能力、8-羟基-2'-脱氧鸟苷、遗传特征及其在阴性慢性和急变期骨髓增殖性肿瘤中的相关性。
Int J Mol Sci. 2024 Jun 17;25(12):6652. doi: 10.3390/ijms25126652.
9
Role of reactive oxygen species in myelodysplastic syndromes.活性氧在骨髓增生异常综合征中的作用。
Cell Mol Biol Lett. 2024 Apr 14;29(1):53. doi: 10.1186/s11658-024-00570-0.
10
Lysophosphatidic Acid Receptor 3 Activation Is Involved in the Regulation of Ferroptosis.溶血磷脂酸受体 3 的激活参与铁死亡的调控。
Int J Mol Sci. 2024 Feb 15;25(4):2315. doi: 10.3390/ijms25042315.